Hiroshi Minematsu
Overview
Explore the profile of Hiroshi Minematsu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
10
Citations
113
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Fischer C, Mikami M, Minematsu H, Nizami S, Goo Lee H, Stamer D, et al.
J Orthop Res
. 2017 May;
35(12):2658-2666.
PMID: 28460421
Osteoclasts play key roles in bone remodeling and pathologic osteolytic disorders such as inflammation, infection, bone implant loosening, rheumatoid arthritis, metastatic bone cancers, and pathological fractures. Osteoclasts are formed by...
2.
Goo Lee H, Minematsu H, Kim K, Celil Aydemir A, Shin M, Nizami S, et al.
Biomaterials
. 2011 Sep;
32(35):9197-206.
PMID: 21899882
Wear particles at the host bone-implant interface are a major challenge for successful bone implant arthoplasties. Current understanding of aseptic loosening consists of macrophage-mediated inflammatory responses and increasing osteoclastogenesis, which...
3.
Minematsu H, Shin M, Celil Aydemir A, Kim K, Nizami S, Chung G, et al.
Cell Signal
. 2011 Jul;
23(11):1785-93.
PMID: 21726630
Nuclear factor of activated T cells (NFATs) are crucial transcription factors that tightly control proinflammatory cytokine expression for adaptive immunity in T and B lymphocytes. However, little is known about...
4.
Noh K, Kim K, Patel N, Staples J, Minematsu H, Nair K, et al.
J Bone Joint Surg Am
. 2011 Apr;
93(8):723-32.
PMID: 21508279
Background: A subset of patients with aggressive osteosarcomas responds poorly to conventional cytotoxic chemotherapy. Recent evidence from studies involving the liver, skin, stomach, and colon suggests that carcinogenesis is associated...
5.
Seo S, Lee D, Minematsu H, Kim A, Shin M, Cho S, et al.
Bone
. 2009 Nov;
46(3):695-702.
PMID: 19895919
The extracellular signal-regulated kinase 1/2 (ERK) pathway, part of the mitogen-activated protein kinase (MAPK) family, is well-known for its role in cell differentiation and proliferation. In the context of osteoclastogenesis,...
6.
Celil Aydemir A, Minematsu H, Gardner T, Kim K, Ahn J, Young-In Lee F
Bone
. 2009 Sep;
46(1):167-75.
PMID: 19748606
Mechanical loading such as interstitial fluid shear stress and tensile strain stimulates bone cells, which respond by changing bone mass and structure to maintain optimal skeletal architecture. Bone cells also...
7.
Seo S, Lee D, Cho S, Kim A, Minematsu H, Celil Aydemir A, et al.
Ann N Y Acad Sci
. 2007 Dec;
1117:151-8.
PMID: 18056041
Periprosthetic osteolysis poses a significant clinical problem for patients who have undergone total joint arthroplastic surgeries. It has been widely recognized that there is a strong correlation between wear particles...
8.
Minematsu H, Shin M, Celil Aydemir A, Seo S, Kim D, Blaine T, et al.
Ann N Y Acad Sci
. 2007 Dec;
1117:143-50.
PMID: 18056040
Wear particles produced from artificial joint prostheses are known to cause macrophage-monocyte lineage cells to produce proosteoclastogenic cytokines, including tumor necrosis factor (TNF)-alpha. The specific molecular mechanism, however, is not...
9.
Ohtsubo E, Minematsu H, Tsuchida K, Ohtsubo H, Sekine Y
Adv Biophys
. 2004 Oct;
38:125-39.
PMID: 15493331
No abstract available.
10.
Ohtsubo E, Minematsu H, Tsuchida K, Ohtsubo H, Sekine Y
Adv Biophys
. 2004 Oct;
38(Complete):125-139.
PMID: 15476896
No abstract available.